Department of Neurology/Emergency department, University Hospital RWTH Aachen
Aachen, North Rhine-Westphalia, 52074, Germany
NCT Number: NCT02926703
The investigators compared the feasibility of serum creatine kinase and serum lactate concentration as diagnostic markers to distinguish between generalized tonic-clonic seizures (GTCS) and syncopes in clinical settings that require fast-action treatment, such as in the emergency departments.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Aachen, North Rhine-Westphalia, 52074, Germany
The patients of this prospective study were selected from a sample of patients who were admitted to the emergency room of the University Hospital RWTH Aachen with an unclear impairment of consciousness. Only patients who later on were diagnosed as having experienced a GTCS or a syncope and whose serum lactate concentrations had been measured within 2 hours after the event were enrolled in the study. The investigators compared the specificity and sensitivity of the serum lactate concentrations at admission with the CK concentration at admission and the CK follow-up taken 10 to 48 hours after the event.
The values at admission were compared between patients from whom a blood sample was collected within 60 minutes after the event, and those from whom a blood sample was collected within 61-120 minutes after the event.
The comparison of initial lactate concentrations at admission with CK levels 10 - 48 hours later could only be performed on part of the patient collective because the other patients were already discharged at this time-point and could therefore not be included.
The initial blood samples were taken at patient arrival in the emergency room. The follow up was performed during the inpatient stay.
Serum lactate and CK concentrations between patient groups were statistically compared with a Mann-Whitney-U test. We defined cut-off values and their sensitivity and specificity by Receiver Operating Characteristic (ROC) analysis.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patients with generalized tonic-clonic seizures and syncopes and whose blood samples were taken within 2 hours after the event
18 years or older
Observed seizure
Time of the event before admission was known
Diagnosis of an epileptic seizure or syncope had been entered in the final discharge report
Exclusion criteria
Prisoner
Age < 18 years old
Competing explanations for serum lactate or CK elevation e.g. shock or trauma
Lack of capacity for consent
Serum lactate and CK concentrations in blood samples were measured routinely at admission
Time frame: 2 hours
Time frame: 48 hours
RWTH Aachen University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04999046
Brain Diseases, Central Nervous System Diseases
Taipei, Taiwan
View Trial DetailsNCT07508670
Brain Diseases, Brain Ischemia
Cork, Ireland
View Trial DetailsNCT06741930
Brain Diseases, Central Nervous System Diseases
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT06703983
Brain Diseases, Central Nervous System Diseases
Mashhad, Razavi Khorasan Province, Iran
View Trial Details